HIV infection in the elderly

被引:26
作者
Gebo K.A. [1 ]
Justice A. [1 ]
机构
[1] Johns Hopkins University School of Medicine, Baltimore, MD 21287
关键词
Tenofovir Disoproxil Fumarate; Acquir Immune; Virologic Suppression; Multicenter AIDS Cohort Study;
D O I
10.1007/s11908-009-0036-0
中图分类号
学科分类号
摘要
The prevalence of HIV in patients over the age of 50 years is increasing. Although older patients may achieve equal or better virologic suppression at equal rates compared with younger patients, the immunologic benefit of highly active antiretroviral therapy (HAART) in older patients may be reduced compared with younger patients. Comorbidities are more common in older patients than younger patients and can impact management of HIV in these patients. Providers must be cognizant of drug-drug interactions and side effects of HAART regimens when selecting an antiretroviral regimen in older HIV patients. As the HIV-infected population ages, there is a growing need to better determine the ideal HAART regimen and timing of HAART initiation in older patients. © Current Medicine Group, LLC 2009.
引用
收藏
页码:246 / 254
页数:8
相关论文
共 78 条
[1]
HIV/AIDS Surveillance Report, 2006, 18, (2008)
[2]
Phillips A.N., Lee C.A., Elford J., Et al., More rapid progression to AIDS in older HIV-infected people: The role of CD4+ T-cell counts, J Acquir Immune Defic Syndr, 4, pp. 970-975, (1991)
[3]
Rothenberg R., Woelfel M., Stoneburner R., Et al., Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City, N Engl J Med, 317, pp. 1297-1302, (1987)
[4]
Balslev U., Monforte A.D., Stergiou G., Et al., Influence of age on rates of new AIDS-defining diseases and survival in 6546 AIDS patients, Scand J Infect Dis, 29, pp. 337-343, (1997)
[5]
AIDS among persons aged > or = 50 years - United States, 1991-1996, MMWR Morb Mortal Wkly Rep, 47, pp. 21-27, (1998)
[6]
Manfredi R., HIV infection and advanced age: Emerging epidemiological, clinical, and management issues, Ageing Res Rev, 3, pp. 31-54, (2004)
[7]
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, MMWR Recomm Rep, 41, pp. 1-19, (1992)
[8]
Mack K.A., Ory M.G., AIDS and older Americans at the end of the twentieth century, J Acquir Immune Defic Syndr, 33, SUPPL. 2, (2003)
[9]
HIV Over Fifty, Exploring the New Threat: Hearings Before the Senate Committee on Aging, (2005)
[10]
Stall R., Catania J., AIDS risk behaviors among late middle-aged and elderly Americans. The National AIDS Behavioral Surveys, Arch Intern Med, 154, pp. 57-63, (1994)